Picture of Liminal BioSciences logo

LMNL — Liminal BioSciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Liminal Biosciences Reports Third Quarter 2022 Financial Results

Nov 9 (Reuters) - Liminal BioSciences Inc  LMNL.O :
    * LIMINAL BIOSCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
    * LIMINAL BIOSCIENCES INC - $40.8M OF CASH AND CASH
EQUIVALENTS AT
SEPTEMBER 30, 2022
    * LIMINAL BIOSCIENCES INC - NICOLE RUSAW, WHO HAS BEEN
SERVING AS
INTERIM CFO SINCE MARCH 2, 2022, HAS BEEN APPOINTED AS CFO
EFFECTIVE IMMEDIATELY
    * LIMINAL BIOSCIENCES INC - NET INCOME WAS $22.3 MILLION FOR
Q3 OF
2022 COMPARED TO INCOME OF $74.5 MILLION FOR Q3 OF 2021

Source text for Eikon:  ID:nPn9yRFpGa 
Further company coverage:  LMNL.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Liminal BioSciences

See all news